Oklahoma Attorney General Mike Hunter plans to appeal a $465 million opioid judgment after the judge refused to extend the abatement funds beyond a year.
The state joins Johnson & Johnson, sole defendant in the case, along with its subsidiary, Janssen Pharmaceuticals, in appealing the Nov. 15 judgment, which followed the first trial in the nation over the opioid crisis. At trial, the state’s lawyers had argued for $17.5 billion paid out over 30 years to fix the opioid crisis in Oklahoma.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Advance® Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
